Journal of Biology and Today's World

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Adverse Drug Reaction Reporting among Iranian Pharmacists: Investigation of Barriers and Attitudes


Author(s): Mehdi Mirzaei Alavijeh, Noozhan Karimi, Behzad Karami Matin, Sadaf Nezamoleslami, Sahar Ahmadvand, Afsoon Vahdat, Mohammad Mahboubi

"Adverse drug reaction (ADR) has been known as a main reason to mortality, which pushes a significant pressure on health care resources; in addition reporting ADR could be helpful to decrease the consequences. The pre-sent study aimed to determine the attitude and barriers of not reporting ADR cases among a group of Iranian pharmacologists. This cross-sectional study was conducted among 117 pharmacists during 2014. Participants were selected in random sampling with probability proportional to size among pharmacy in the west of Iran. Data were collected by using questionnaire in self-report. Data were analyzed by SPSS version 21 using t statistical tests and bivariate correlations. Mean score of the ADR report barriers was 17.82 years (ranging from 7 to 35 years). Lack of motivation, not having report forms available, inefficiency of reporting and lack of investigations received higher scores as major barriers. Also, increasing the trust between patients and pharmacist, decreasing health care system charges and efficiency had the highest mean scores considering attitudes. Generally, there was a meaningful statistical relationship between reporting ADR by pharmacist and barriers (P = 0.007). Accord-ing to the results from the present study, it seems essential to hold retraining programs in order to improve re-porting ADRs by pharmacists, introducing advantages of reporting ADRs and removing barriers to report ADRs."

Share this article

Reach Us

Avenue Roger Vandendriessche 18,
1150 Brussels, Belgium
Toll Free +32 (800) 709-48

Contact Us

E-Mail: [email protected]

© Lexispublisher 2020 | Creative Commons License Open Access Journals by Lexispublisher is licensed under a Creative Commons Attritbution 4.0 International License